Section 29 (New Zealand) in Lebanon
How the section 29 (new zealand) pathway operates in Lebanon.
About Section 29 (New Zealand)
New Zealand's Medsafe pathway for unapproved medicines.
How Section 29 (New Zealand) works in Lebanon
Lebanon's MoPH has a functional (if under-resourced) named-patient pathway for unregistered drugs.
Patients in Lebanon seeking access under Section 29 (New Zealand) typically follow this flow: a licensed physician in Lebanon issues the prescription and clinical justification, the regulator reviews and authorises, and an authorised operator coordinates import.
Documents required in Lebanon
- Physician prescription and clinical-justification letter.
- Patient identification and consent.
- Country-specific NPP/personal-import form.
- Hospital or clinic attestation where required.
Typical timeline
End-to-end 2-6 weeks in most tier 3 jurisdictions. Cellular and gene therapies may require additional ethics-committee review.